The 2025 YouGov survey data from more than 31,000 US adults show significant support for recreational cannabis legalization, medical use, and federal reclassification.
|Articles|March 10, 2022
Senate Majority Leader Chuck Schumer Announces Updates to Bill to Federally Legalize Cannabis
Author(s)Erin McEvoy
In February, Senate Majority Leader Chuck Schumer explained in a press conference and in a letter to colleagues the details of his bill to federally legalize cannabis and announced his plan to introduce it in the coming weeks.
Advertisement
Senate Majority Leader Chuck Schumer announced his plans to file a bill in April 2022 to federally legalize cannabis (1,2). He also said in a letter to colleagues that he and other senators have already received comments on the draft from a broad array of relevant sources and are requesting input from leaders of relevant committees and from senators who have dealt with legalization in their own states.
Schumer first disclosed details about his Cannabis Administration & Opportunity Act (CAOA), which he unveiled in draft form for public comment in July 2021, and he expects committee hearings on the proposal shortly after it’s formally filed.
“One major hurdle continues to stand in the way of states’ ability to make their own decisions about cannabis—the continued prohibition of marijuana at the federal level,” said Schumer. “As more and more states move to legalize cannabis for both adult and medical use, the federal government has an important role to play. Hundreds of millions of Americans live in states that have legalized cannabis in some form while it remains illegal at the federal level.”
The proposal would federally deschedule cannabis, expunge prior convictions, allow people to petition for resentencing, maintain the authority of states to set their own cannabis policies, and remove collateral consequences such as immigration-related penalties for people who’ve been criminalized over the plant.
The bill would also impose a federal tax on cannabis products and direct some of that revenue to grant programs meant to support people from communities most impacted by the prohibition who want to participate in the industry. It would transfer regulatory authority over cannabis from the US Drug Enforcement Administration (DEA) to the Food and Drug Administration (FDA), the Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF), and the Alcohol and Tobacco Tax and Trade Bureau (TTB).
References
Advertisement
Related to this article
Curaleaf is opening a new cannabis dispensary called Curaleaf Millcreek in Erie, Pennsylvania.
Learn how third-party audits enhance compliance in the cannabis industry, ensuring readiness for evolving regulations and fostering consumer trust.
Let’s take a look at the 2025 cannabis coverage on medical cannabis research and medicine to catch up on industry trends and innovations.
Let’s take a look at the 2025 cannabis coverage on cannabis research to catch up on industry trends and innovations.
A lack of standards for cannabis vape devices puts consumers at risk, but several organizations are committed to the research, collaboration, and solutions needed to promote safety and quality in the industry.
Cannabis genetics fundamentally dictate the plant's potential for chemical signatures, including cannabinoid and terpene profiles, and physical traits, such as yield. Cultivators use selective techniques, such as "stacking," to enhance specific compounds. Ultimately, successful cultivation involves balancing superior genetics with environmental "levers" to optimize gene expression and create targeted strains.
It’s that time of year again—the Cannabis Science and Technology (CST) top 10 articles from the previous year. CST published a wide variety of content throughout 2025. Here is just a small snippet of some of the top articles that our readers enjoyed. See if any of your favorites made the list!
Advertisement
Advertisement